Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$111,656
in 2 filings

Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Douglas Earl Martin −$63K SVP, General Counsel sold 6% of stake
  2. Parker Geoffrey M. −$49K CHIEF FINANCIAL OFFICER sold 3% of stake

Reading 47 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-13 MESSEMER DEBORAH M. Director Grant or award +74,561 81,096
2023-06-13 Barrett Elizabeth A. Director Grant or award · Stock Option (Right to Buy) +116,120 116,120
2023-06-13 SATO VICKI L Director Grant or award +59,649 101,100
2023-06-13 SATO VICKI L Director Grant or award · Stock Option (Right to Buy) +23,224 23,224
2023-06-13 Humer Franz B Director Grant or award +74,561 266,453
2023-06-13 WITTE OWEN N. Director Grant or award +74,561 292,832
2023-06-13 Mayo Stephen Director Grant or award · Stock Option (Right to Buy) +116,120 116,120
2023-06-13 Kazam Joshua A Director Grant or award · Stock Option (Right to Buy) +116,120 116,120
2023-04-24 MOORE TIMOTHY L. Chief Technical Officer Grant or award +186,219 186,219
2023-04-24 MOORE TIMOTHY L. Chief Technical Officer Grant or award · Stock Option (Right to Buy) +831,024 831,024
2023-04-01 Smith Lillian VP, Corporate Counsel Grant or award +56,545 140,390
2023-03-22 MOORE ALISON Chief Technical Officer Grant or award +558,094 672,731
2023-03-22 MOORE ALISON Chief Technical Officer Grant or award · Stock Option (Right to buy) +432,738 432,738
2023-03-22 SCHMIDT ERIC THOMAS Chief Financial Officer Grant or award +558,094 862,439
2023-03-22 SCHMIDT ERIC THOMAS Chief Financial Officer Grant or award · Stock Option (Right to Buy) +432,738 432,738
2023-03-22 Roberts Zachary EVP of R&D Grant or award +148,035 399,943
2023-03-22 Belldegrun Arie Director Grant or award +1,282,976 1,654,886
2023-03-22 Belldegrun Arie Director Grant or award · Stock Option (Right to Buy) +994,800 994,800
2023-03-22 Chang David D President and CEO Grant or award +1,924,464 4,193,911
2023-03-22 Chang David D President and CEO Grant or award · Stock Option (Right to Buy) +1,492,200 1,492,200

Page 7 of 18 · 348 trades